ResearcherYokohama City UniversityNo recent work listed

Yuzo Minegishi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0002-8655-9632; OpenAlex author ID A5040061979. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2022: 1 paper

Papers 1

CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. Co-author DOI 10.21873/anticanres.15537 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Keiichi Yazawa · 1 shared paper, 2022 · strength 0.15
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537 ↗
Yuki Homma · 1 shared paper, 2022 · strength 0.15
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537 ↗
Yasuhiro Yabushita · 1 shared paper, 2022 · strength 0.15
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537 ↗
Yukihiko Hiroshima · 1 shared paper, 2022 · strength 0.15
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537 ↗
Itaru Endo · 1 shared paper, 2022 · strength 0.15
- Paper CRMP4 Up-regulates M2 Macrophages and Myeloid-derived Suppressor Cells to Promote Pancreatic Cancer in Mice. DOI 10.21873/anticanres.15537 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.